Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Thermo Fisher Scientific stock price, quote, forecast and news

TMO
US8835561023
857209

Price

574.73
Today +/-
+0
Today %
+0 %
P

Thermo Fisher Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Thermo Fisher Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Thermo Fisher Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Thermo Fisher Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Thermo Fisher Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Thermo Fisher Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Thermo Fisher Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Thermo Fisher Scientific’s growth potential.

Thermo Fisher Scientific Revenue, EBIT and net profit per share

DateThermo Fisher Scientific RevenueThermo Fisher Scientific EBITThermo Fisher Scientific Net Income
2028e55.27 B undefined13.4 B undefined13.5 B undefined
2027e52.74 B undefined12.93 B undefined11.89 B undefined
2026e49.94 B undefined11.84 B undefined10.49 B undefined
2025e46.55 B undefined10.84 B undefined9.38 B undefined
2024e43.42 B undefined9.8 B undefined8.38 B undefined
202342.86 B undefined7.32 B undefined6 B undefined
202244.92 B undefined8.51 B undefined6.95 B undefined
202139.21 B undefined10.37 B undefined7.73 B undefined
202032.22 B undefined7.87 B undefined6.38 B undefined
201925.54 B undefined4.24 B undefined3.7 B undefined
201824.36 B undefined3.86 B undefined2.94 B undefined
201720.92 B undefined3.14 B undefined2.23 B undefined
201618.27 B undefined2.74 B undefined2.02 B undefined
201516.97 B undefined2.5 B undefined1.98 B undefined
201416.89 B undefined2.04 B undefined1.89 B undefined
201313.09 B undefined1.76 B undefined1.27 B undefined
201212.51 B undefined1.56 B undefined1.18 B undefined
201111.56 B undefined1.35 B undefined1.33 B undefined
201010.39 B undefined1.25 B undefined1.02 B undefined
20099.91 B undefined1.06 B undefined850 M undefined
200810.5 B undefined1.26 B undefined979 M undefined
20079.75 B undefined1.02 B undefined748 M undefined
20063.79 B undefined288 M undefined169 M undefined
20052.63 B undefined280 M undefined223 M undefined
20042.21 B undefined254 M undefined362 M undefined

Thermo Fisher Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.190.240.280.330.380.540.620.720.810.951.361.732.272.931.981.882.32.282.191.851.92.212.633.799.7510.59.9110.3911.5612.5113.0916.8916.9718.2720.9224.3625.5432.2239.2144.9242.8643.4246.5549.9452.7455.27
-24.2117.8019.4215.3639.6916.4515.7311.6517.8942.7827.6031.2929.21-32.49-5.0022.01-0.61-4.08-15.492.7016.1719.3644.02157.017.72-5.584.8511.228.234.6429.030.447.7214.4716.454.8626.1421.7114.55-4.581.327.207.295.614.79
37.8932.6334.5331.3333.1633.0831.9435.3733.7935.8344.2146.3345.4243.4746.5246.4145.7144.8043.8345.9246.3445.9745.3941.3539.0340.0639.3341.0141.4742.3342.2444.3645.7245.8045.1544.5844.3549.6250.0842.2439.90-----
0.070.080.10.10.130.180.20.260.270.340.60.81.031.280.920.871.051.020.960.850.881.011.21.573.84.213.94.264.795.35.537.497.768.379.4510.8611.3315.9919.6418.9717.100000
0.010.010.020.010.010.020.020.040.040.070.130.180.250.280.290.220.220.20.170.210.230.250.280.291.021.261.061.251.351.561.762.042.52.743.143.864.247.8710.378.517.329.810.8411.8412.9313.4
4.215.088.633.613.394.493.535.275.227.179.3010.5810.889.6814.3911.439.548.687.6311.2512.2211.5110.637.5910.4212.0410.7212.0111.6612.5013.4512.0514.7215.0015.0315.8616.6224.4126.4418.9417.0822.5623.2923.7124.5124.24
00.010.010.010.020.020.030.040.050.060.080.110.140.190.240.18-0.18-0.04-00.310.20.360.220.170.750.980.851.021.331.181.271.891.982.022.232.943.76.387.736.9568.389.3810.4911.8913.5
--66.6740.0028.5727.7817.3929.6334.2925.5330.5136.3633.3336.4325.13-23.85-196.15-79.43-97.22-31,100.00-35.4881.00-38.40-24.22342.6030.88-13.1820.2430.14-11.438.0648.784.282.3810.0432.0425.8072.4821.18-10.03-13.7439.7011.9911.7913.4213.50
----------------------------------------------
----------------------------------------------
45475861697580839410613115115917617616315817118418717116816520444443542340938536736640240239739840640339939739438800000
----------------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Thermo Fisher Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Thermo Fisher Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Thermo Fisher Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Thermo Fisher Scientific's financial health and stability.

Assets

Thermo Fisher Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Thermo Fisher Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Thermo Fisher Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Thermo Fisher Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (B)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993null19941995199619971998null1999nullnull200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.010.020.020.030.040.050.060.080.080.10.140.190.240.180.24-0.170.18-0.17-0.0400.310.20.360.220.170.750.980.851.041.331.181.271.891.982.022.232.943.76.387.736.965.96
0.010.010.010.010.020.020.030.040.040.070.090.120.140.080.140.090.160.110.10.10.040.050.070.120.240.760.790.760.740.860.9811.681.691.762.032.272.282.332.593.383.41
-404-2001214139420101-282-61-39-1622-173-5-73-98-131-243-266-123-301-472-621-524-620-1,098-379-302-552-647-995-1,300
0-1-2015-21-17-43-52-248-47-98-11538-1155-49-8-439-518-29-30-99-24-317115-162-265-34120167-436-178494-570-665-395-1,548-1,049-537
-0.01-0.01-0-0-0.01-0.01-00.020.0200.02-00.010.030.010.440.030.470.090.09-0.22-0.02-0.14-0.040.170.10.150.240.23-0.030.290.18-0.390.240.410.510.470.150.731.421.161.16
00.010.010.010.010.020.020.030.030.050.070.090.10.080.10.090.090.070.080.060.050.020.010.020.040.140.130.10.080.120.230.220.440.4400.530.690.790.470.560.671.39
000.010.010.010.020.020.010.010.030.050.090.150.090.150.070.120.070.090.040.060.030.040.090.120.120.290.310.370.50.290.230.590.4800.480.590.91.322.181.231.48
0.010.020.010.050.020.040.050.10.130.190.20.220.270.330.270.340.330.340.070.180.110.210.260.270.411.481.421.661.51.692.042.012.622.823.264.014.544.978.299.319.158.41
-9-10-21-27-24-33-60-62-56-65-64-124-111-38-111-61-148-87-74-84-41-41-50-43-76-175-264-200-245-260-315-282-427-422-444-508-758-926-1,474-2,523-2,243-1,479
-57-80-35-102-78-294-410-405-399-455-384-1,311-319-632-319-73-632-7322917446330834-753283-586-450-829-858-5,142-1,370-263-11,782-1,087-5,520-7,729-1,253-1,487-1,510-21,932-2,159-5,142
-48-69-13-74-53-261-350-342-342-390-320-1,186-208-594-208-12-4841330325850435084-709360-410-185-629-613-4,881-1,05519-11,355-664-5,076-7,221-495-561-36-19,40984-3,663
000000000000000000000000000000000000000000
0.050.080.030.070.020.220.360.120.090.360.190.880.390.360.3900.29-0.03-0.17-0.06-0.26-0.64-0.010.37-0.16-0.47-0.15-0.2-0.374.710.13.351.88-1.934.173.03-1.56-1.412.758.910.65-0.16
0.01-0-0.020.010.050.050.060.320.32-0.040.070.16-0.15-0.06-0.15-0.18-0.18-0.180.01-0.44-0.31-0.01-0.170.03-0.12-0.55-0.1-0.36-0.94-1.18-0.90.143.1-0.38-1.161.07-0.36-1.35-1.3-1.84-3-3
0.060.080.010.090.080.270.420.440.410.320.261.040.240.10.24-0.290.1-0.29-0.14-0.7-0.59-0.66-0.180.39-0.26-0.93-0.23-0.56-1.33.55-0.923.314.8-2.492.763.85-2.24-3.120.966.58-2.81-3.62
0000-1003010-1-4-200-4-113-5-8413-194-16-110-21796252122018305758-14-3-51-69-147-91-956
000000000000000000000000000000-142-216-234-240-238-237-266-297-337-395-455-523
0.010.02-0.010.040.020.010.060.130.140.060.08-0.050.18-0.20.18-0.04-0.2-0.040.15-0.34-0-0.110.13-0.110.45-0.040.660.28-0.650.1-0.215.02-4.48-0.890.350.550.760.317.91-5.854.05-0.44
3.59.8-7.924.4-2.95.9-5.138.60127135.1100157.4290.20275.900-4.89865.4173214.5227.4328.91,3081,155.81,459.21,252.41,430.11,724.41,728.32,1922,3942,8143,4973,7854,0476,8156,7896,9116,927
000000000000000000000000000000000000000000

Thermo Fisher Scientific stock margins

The Thermo Fisher Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thermo Fisher Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thermo Fisher Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Thermo Fisher Scientific's sales revenue. A higher gross margin percentage indicates that the Thermo Fisher Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Thermo Fisher Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Thermo Fisher Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Thermo Fisher Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Thermo Fisher Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Thermo Fisher Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Thermo Fisher Scientific Margin History

Thermo Fisher Scientific Gross marginThermo Fisher Scientific Profit marginThermo Fisher Scientific EBIT marginThermo Fisher Scientific Profit margin
2028e39.9 %24.24 %24.42 %
2027e39.9 %24.51 %22.55 %
2026e39.9 %23.71 %21 %
2025e39.9 %23.29 %20.15 %
2024e39.9 %22.56 %19.29 %
202339.9 %17.08 %13.99 %
202242.24 %18.94 %15.47 %
202150.08 %26.44 %19.7 %
202049.62 %24.41 %19.79 %
201944.35 %16.62 %14.47 %
201844.58 %15.86 %12.06 %
201745.15 %15.03 %10.64 %
201645.8 %15 %11.06 %
201545.72 %14.72 %11.64 %
201444.36 %12.05 %11.21 %
201342.24 %13.45 %9.72 %
201242.33 %12.5 %9.42 %
201141.47 %11.66 %11.51 %
201041.01 %12.01 %9.83 %
200939.33 %10.72 %8.58 %
200840.06 %12.04 %9.33 %
200739.03 %10.42 %7.67 %
200641.35 %7.59 %4.46 %
200545.39 %10.63 %8.47 %
200445.97 %11.51 %16.41 %

Thermo Fisher Scientific Stock Sales Revenue, EBIT, Earnings per Share

The Thermo Fisher Scientific earnings per share therefore indicates how much revenue Thermo Fisher Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermo Fisher Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermo Fisher Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermo Fisher Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermo Fisher Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermo Fisher Scientific Revenue, EBIT and net profit per share

DateThermo Fisher Scientific Sales per ShareThermo Fisher Scientific EBIT per shareThermo Fisher Scientific Earnings per Share
2028e144.79 undefined0 undefined35.36 undefined
2027e138.17 undefined0 undefined31.15 undefined
2026e130.83 undefined0 undefined27.47 undefined
2025e121.94 undefined0 undefined24.57 undefined
2024e113.76 undefined0 undefined21.94 undefined
2023110.46 undefined18.86 undefined15.45 undefined
2022114 undefined21.59 undefined17.64 undefined
202198.77 undefined26.12 undefined19.46 undefined
202080.75 undefined19.71 undefined15.98 undefined
201963.38 undefined10.53 undefined9.17 undefined
201860 undefined9.52 undefined7.24 undefined
201752.56 undefined7.9 undefined5.59 undefined
201646.03 undefined6.91 undefined5.09 undefined
201542.2 undefined6.21 undefined4.91 undefined
201442.01 undefined5.06 undefined4.71 undefined
201335.77 undefined4.81 undefined3.48 undefined
201234.09 undefined4.26 undefined3.21 undefined
201130.02 undefined3.5 undefined3.45 undefined
201025.41 undefined3.05 undefined2.5 undefined
200923.43 undefined2.51 undefined2.01 undefined
200824.13 undefined2.91 undefined2.25 undefined
200721.95 undefined2.29 undefined1.68 undefined
200618.59 undefined1.41 undefined0.83 undefined
200515.96 undefined1.7 undefined1.35 undefined
200413.13 undefined1.51 undefined2.15 undefined

Thermo Fisher Scientific business model

Thermo Fisher Scientific Inc - A global market leader Thermo Fisher Scientific is one of the most popular companies on Eulerpool.com.

Thermo Fisher Scientific SWOT Analysis

Strengths

Thermo Fisher Scientific Inc offers a diverse portfolio of products, including scientific instruments, consumables, reagents, software, and services. This extensive range allows them to cater to the needs of various industries and customers, providing a strong competitive advantage.

Thermo Fisher Scientific Inc has established a strong brand reputation in the scientific research and healthcare sectors. Their commitment to innovation, quality, and reliability has earned the trust of customers worldwide, boosting their market position and customer loyalty.

Thermo Fisher Scientific Inc operates globally and has a well-established distribution network. Their wide geographic presence allows them to reach customers worldwide efficiently and effectively, contributing to their market share dominance and revenue growth.

Weaknesses

Thermo Fisher Scientific Inc heavily relies on continuous research and development activities for new product development and improvement. Any disruption or failure in R&D efforts could impact their ability to innovate and maintain a competitive edge in the market.

Thermo Fisher Scientific Inc operates in highly regulated industries, such as healthcare and pharmaceuticals. Changes in government regulations and policies can significantly impact their operations, requiring compliance adjustments that may incur additional costs or restrict market access.

Opportunities

The advancement of precision medicine presents an opportunity for Thermo Fisher Scientific Inc as it aligns with their expertise in genomics, proteomics, and other precision research areas. The increasing demand for personalized healthcare solutions can drive the adoption of their products and services.

Thermo Fisher Scientific Inc can capitalize on the rapid growth of emerging markets, such as Asia-Pacific and Latin America. By expanding their presence in these regions and adapting to local market needs, they can tap into new customer segments and boost their revenue streams.

Threats

Thermo Fisher Scientific Inc faces fierce competition from other global players and niche market entrants. The competitive landscape poses a threat to their market share, pricing power, and customer acquisition, necessitating consistent innovation, marketing, and strategic efforts to maintain their competitive position.

Fluctuations in the global economy, currency exchange rates, and geopolitical events can impact Thermo Fisher Scientific Inc's financial performance. Economic uncertainties, recessions, or downturns may reduce customer spending on scientific research and healthcare, affecting their sales and profitability.

Thermo Fisher Scientific historical P/E ratio, EBIT, and P/S ratio.

Thermo Fisher Scientific shares outstanding

The number of shares was Thermo Fisher Scientific in 2023 — This indicates how many shares 388 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermo Fisher Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermo Fisher Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermo Fisher Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermo Fisher Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermo Fisher Scientific Stock splits

In Thermo Fisher Scientific's history, there have been no stock splits.

Thermo Fisher Scientific dividend history and estimates

In 2023, Thermo Fisher Scientific paid a dividend amounting to 1.4 USD. Dividend means that Thermo Fisher Scientific distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Thermo Fisher Scientific provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Thermo Fisher Scientific’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Thermo Fisher Scientific's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Thermo Fisher Scientific Dividend History

DateThermo Fisher Scientific Dividend
2028e1.61 undefined
2027e1.61 undefined
2026e1.61 undefined
2025e1.61 undefined
2024e1.61 undefined
20231.4 undefined
20221.2 undefined
20211.04 undefined
20200.88 undefined
20190.76 undefined
20180.68 undefined
20170.6 undefined
20160.6 undefined
20150.6 undefined
20140.6 undefined
20130.6 undefined
20120.54 undefined

Thermo Fisher Scientific dividend payout ratio

In 2023, Thermo Fisher Scientific had a payout ratio of 5.88%. The payout ratio indicates the percentage of the company's profits that Thermo Fisher Scientific distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Thermo Fisher Scientific represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Thermo Fisher Scientific could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Thermo Fisher Scientific's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Thermo Fisher Scientific Payout Ratio History

DateThermo Fisher Scientific Payout ratio
2028e6.12 %
2027e6.1 %
2026e6.04 %
2025e6.23 %
2024e6.01 %
20235.88 %
20226.8 %
20215.34 %
20205.51 %
20198.27 %
20189.41 %
201710.73 %
201611.76 %
201512.17 %
201412.74 %
201317.29 %
201216.87 %
20115.88 %
20105.88 %
20095.88 %
20085.88 %
20075.88 %
20065.88 %
20055.88 %
20045.88 %
Unfortunately, there are currently no price targets and forecasts available for Thermo Fisher Scientific.

Thermo Fisher Scientific latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20245.18 5.37  (3.75 %)2024 Q2
3/31/20244.76 5.11  (7.43 %)2024 Q1
12/31/20235.7 5.67  (-0.54 %)2023 Q4
9/30/20235.67 5.69  (0.43 %)2023 Q3
6/30/20235.48 5.15  (-6.02 %)2023 Q2
3/31/20235.08 5.03  (-0.92 %)2023 Q1
12/31/20225.25 5.4  (2.9 %)2022 Q4
9/30/20224.86 5.08  (4.52 %)2022 Q3
6/30/20225.04 5.51  (9.39 %)2022 Q2
3/31/20226.24 7.25  (16.14 %)2022 Q1
1
2
3
4
5
...
11

Eulerpool ESG Scorecard© for the Thermo Fisher Scientific stock

Eulerpool World ESG Rating (EESG©)

88/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

66

Environment

Scope 1 - Direct Emissions
298,043
Scope 2 - Indirect emissions from purchased energy
365,356
Scope 3 - Indirect emissions within the value chain
11,702,924
Total CO₂ emissions
663,399
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
✅
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees40.5
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies✅
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Thermo Fisher Scientific list of shareholders

%
Name
Stocks
Change
Date
8.60 % The Vanguard Group, Inc.32,811,604213,48112/31/2023
4.50 % BlackRock Institutional Trust Company, N.A.17,168,425227,86212/31/2023
4.32 % State Street Global Advisors (US)16,476,884835,29512/31/2023
3.21 % Capital World Investors12,262,793-492,21412/31/2023
2.45 % T. Rowe Price Associates, Inc.9,346,561-244,17712/31/2023
2.09 % Capital Research Global Investors7,989,614517,13712/31/2023
1.92 % Fidelity Management & Research Company LLC7,340,734-446,15312/31/2023
1.91 % Geode Capital Management, L.L.C.7,291,893173,55412/31/2023
1.44 % Norges Bank Investment Management (NBIM)5,481,498-158,11312/31/2023
1.08 % Morgan Stanley Smith Barney LLC4,124,000-145,53612/31/2023
1
2
3
4
5
...
10

Thermo Fisher Scientific Executives and Management Board

Mr. Marc Casper55
Thermo Fisher Scientific Chairman of the Board, President, Chief Executive Officer (since 2001)
Compensation 14.16 M
Mr. Michel Lagarde49
Thermo Fisher Scientific Chief Operating Officer, Executive Vice President
Compensation 8.06 M
Mr. Stephen Williamson56
Thermo Fisher Scientific Chief Financial Officer, Senior Vice President
Compensation 6.85 M
Mr. Gianluca Pettiti44
Thermo Fisher Scientific Executive Vice President (since 2021)
Compensation 5.74 M
Mr. Michael Boxer60
Thermo Fisher Scientific Senior Vice President, General Counsel
Compensation 3.12 M
1
2
3
4

Thermo Fisher Scientific Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Immuron Stock
Immuron
SupplierCustomer----0,46-0,460,33
NanoEnTek Stock
NanoEnTek
SupplierCustomer0,920,48-0,67-0,69-0,41-
OraSure Technologies Stock
OraSure Technologies
SupplierCustomer0,880,850,540,700,060,34
Shenzhen Mindray Bio-Medical Electronics A Stock
Shenzhen Mindray Bio-Medical Electronics A
SupplierCustomer0,790,80-0,87-0,79-0,200,82
Horizon Therapeutics Public Limited Company Stock
Horizon Therapeutics Public Limited Company
SupplierCustomer0,760,220,880,910,610,95
Evoke Pharma Stock
Evoke Pharma
SupplierCustomer0,760,47-0,61-0,60-0,420,19
ACADIA Pharmaceuticals Inc. Stock
ACADIA Pharmaceuticals Inc.
SupplierCustomer0,71-0,32-0,93-0,65-0,37-0,46
Quanterix Corporation Stock
Quanterix Corporation
SupplierCustomer0,71--0,76-0,39-0,01-
Xencor Stock
Xencor
SupplierCustomer0,670,51-0,20-0,75-0,530,44
Judges Scientific Stock
Judges Scientific
SupplierCustomer0,670,350,920,710,570,83
1
2
3
4
5
...
15

Most common questions regarding Thermo Fisher Scientific

What values and corporate philosophy does Thermo Fisher Scientific represent?

Thermo Fisher Scientific Inc represents values centered on innovation, integrity, and customer focus. As a global leader in serving science, the company is committed to enabling their customers to make the world a healthier, cleaner, and safer place. Thermo Fisher Scientific Inc strives to provide cutting-edge technologies and solutions in the fields of life sciences, healthcare, and diagnostics. With a strong emphasis on research and development, their corporate philosophy aims to improve human health and wellbeing through constant innovation and collaboration with their customers. Thermo Fisher Scientific Inc is dedicated to delivering reliable and high-quality products and services that contribute to scientific advancements worldwide.

In which countries and regions is Thermo Fisher Scientific primarily present?

Thermo Fisher Scientific Inc is primarily present in multiple countries and regions worldwide. The company operates in North America, including the United States and Canada, where it has a strong presence. Additionally, Thermo Fisher Scientific Inc has a significant presence throughout Europe, with operations in countries such as the United Kingdom, Germany, France, and Spain. The company also serves customers in Asia, including China, India, Japan, and South Korea. Thermo Fisher Scientific Inc is expanding its footprint in emerging markets like Latin America and Africa, aiming to provide its products and services to customers globally.

What significant milestones has the company Thermo Fisher Scientific achieved?

Thermo Fisher Scientific Inc has achieved several significant milestones throughout its history. The company completed the acquisition of Life Technologies Corporation in 2014, which expanded its offerings in the life sciences field. Additionally, Thermo Fisher Scientific has made strides in advancing precision medicine and genetic research, developing innovative solutions for healthcare professionals. The company has also received recognition for its initiatives in sustainability, being included in the Dow Jones Sustainability World Index multiple times. Furthermore, Thermo Fisher Scientific has consistently reported robust financial performance, driving growth and shareholder value.

What is the history and background of the company Thermo Fisher Scientific?

Thermo Fisher Scientific Inc is a renowned company with a rich history and background. Established in 2006 through the merger of Thermo Electron and Fisher Scientific, it is now a global leader in serving the scientific research, pharmaceutical, and healthcare industries. With a diverse portfolio of innovative products and services, Thermo Fisher Scientific enables its customers to make important discoveries, enhance diagnostics, and improve overall patient care. The company's commitment to providing advanced solutions and expertise has propelled its growth, establishing it as a trusted partner in the scientific community. Today, Thermo Fisher Scientific continues to drive innovation and shape the future of scientific research and healthcare worldwide.

Who are the main competitors of Thermo Fisher Scientific in the market?

The main competitors of Thermo Fisher Scientific Inc in the market include Agilent Technologies, Danaher Corporation, and Illumina Inc.

In which industries is Thermo Fisher Scientific primarily active?

Thermo Fisher Scientific Inc is primarily active in the life sciences, healthcare, and research industries.

What is the business model of Thermo Fisher Scientific?

Thermo Fisher Scientific Inc is a renowned company that operates in the scientific research and healthcare sector. The business model of Thermo Fisher Scientific Inc centers around providing a wide range of products, services, and solutions to enable scientific discoveries and advancements. The company offers innovative instruments, consumables, software, and services to enable scientists and researchers to address complex challenges in various fields such as life sciences, pharmaceutical, biotechnology, and more. Thermo Fisher Scientific Inc also focuses on providing analytical instruments, reagents, consumables, software, and services to support healthcare professionals in diagnosing and treating various diseases. With its comprehensive offerings, Thermo Fisher Scientific Inc strives to empower its customers to make the world healthier, cleaner, and safer.

What is the P/E ratio of Thermo Fisher Scientific 2024?

The Thermo Fisher Scientific P/E ratio is 26.63.

What is the P/S ratio of Thermo Fisher Scientific 2024?

The Thermo Fisher Scientific P/S ratio is 5.14.

What is the AlleAktien quality score of Thermo Fisher Scientific?

The AlleAktien quality score for Thermo Fisher Scientific is 6/10.

What is the revenue of Thermo Fisher Scientific 2024?

The expected Thermo Fisher Scientific revenue is 43.42 B USD.

How high is the profit of Thermo Fisher Scientific 2024?

The expected Thermo Fisher Scientific profit is 8.38 B USD.

What is the business model of Thermo Fisher Scientific

Thermo Fisher Scientific Inc is a global leading company in the field of laboratory analysis and diagnostic devices. The business model of Thermo Fisher Scientific Inc is based on providing solutions to businesses, government agencies, hospitals, research institutions, and many other customers. The company offers a variety of products and services in different business areas, including life sciences, diagnostics, analytics, and laboratory products. Thermo Fisher Scientific Inc has a strong presence in over 50 countries and serves customers in various industries and regions. Its wide range of products and services includes solutions for scientists and researchers in developing new drugs, improving healthcare, and protecting the environment. Additionally, the company offers diagnostic solutions for laboratories and physicians to enhance patient care, as well as specialized products and solutions for material analysis. Thermo Fisher Scientific Inc also provides a wide range of laboratory products and offers services such as system integration, validation, qualification, training, and support. With continuous research and development, acquisitions, and collaboration with customers, the company aims to expand and enhance its expertise in the field of science and technology.

What is the Thermo Fisher Scientific dividend?

Thermo Fisher Scientific pays a dividend of 1.2 USD distributed over 4 payouts per year.

How often does Thermo Fisher Scientific pay dividends?

Thermo Fisher Scientific pays out a dividend 4 times a year.

What is the Thermo Fisher Scientific ISIN?

The ISIN of Thermo Fisher Scientific is US8835561023.

What is the Thermo Fisher Scientific WKN?

The WKN of Thermo Fisher Scientific is 857209.

What is the Thermo Fisher Scientific ticker?

The ticker of Thermo Fisher Scientific is TMO.

How much dividend does Thermo Fisher Scientific pay?

Over the past 12 months, Thermo Fisher Scientific paid a dividend of 1.4 USD . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, Thermo Fisher Scientific is expected to pay a dividend of 1.61 USD.

What is the dividend yield of Thermo Fisher Scientific?

The current dividend yield of Thermo Fisher Scientific is 0.24 %.

When does Thermo Fisher Scientific pay dividends?

Thermo Fisher Scientific pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Thermo Fisher Scientific?

Thermo Fisher Scientific paid dividends every year for the past 17 years.

What is the dividend of Thermo Fisher Scientific?

For the upcoming 12 months, dividends amounting to 1.61 USD are expected. This corresponds to a dividend yield of 0.26 %.

In which sector is Thermo Fisher Scientific located?

Thermo Fisher Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Thermo Fisher Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Thermo Fisher Scientific from 10/15/2024 amounting to 0.39 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Thermo Fisher Scientific pay the last dividend?

The last dividend was paid out on 10/15/2024.

What was the dividend of Thermo Fisher Scientific in the year 2023?

In the year 2023, Thermo Fisher Scientific distributed 1.2 USD as dividends.

In which currency does Thermo Fisher Scientific pay out the dividend?

The dividends of Thermo Fisher Scientific are distributed in USD.

All fundamentals about Thermo Fisher Scientific

Our stock analysis for Thermo Fisher Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thermo Fisher Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.